Momepax Control (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momepax Control, is a potent corticosteroid formulated as a nasal spray for intranasal administration. It is indicated for the treatment of seasonal and perennial allergic rhinitis, providing anti‑inflammatory relief of nasal congestion, sneezing and itching in both adult and pediatric patients.

GNH USA supplies Momepax Control as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics across global markets through adhering to EU quality standards and regulatory requirements worldwide.

Momepax Control, containing mometasone furoate, is used to manage inflammatory conditions of the nasal mucosa, primarily allergic rhinitis. - Seasonal allergic rhinitis: alleviates nasal congestion, sneezing and itching during pollen seasons. - Perennial allergic rhinitis: provides continuous symptom control for year‑round allergen exposure. - Nasal symptoms of allergic rhinitis: reduces inflammation and improves airflow in the nasal passages.

Momepax Control may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Altered taste or post‑nasal drip. - Throat irritation. - Cough.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe or prolonged epistaxis. - Adrenal suppression with systemic effects. - Vision changes such as cataracts or glaucoma. - Opportunistic fungal infection of the nasal passages.

Before using Momepax Control, consider the following precautions. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Use in children: follow pediatric dosing guidance. - Avoid concurrent nasal surgery: may impair postoperative healing. - Monitor for signs of adrenal suppression: report unusual fatigue or weakness. - Store at room temperature: keep in the original container, protect from moisture and heat.

Momepax Control can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local mometasone exposure. - Antifungal azoles: potential for heightened steroid activity.

Moderate Interactions (Monitor Closely): - Antihistamines: additive sedation is uncommon but monitor patient response. - Live vaccines: nasal steroid may slightly reduce immune response. - Ritonavir or other potent CYP3A4 modulators: may modestly increase mometasone levels.